🇺🇸 FDA
Pipeline program

Selinexor

SENTINEL

Phase 1 small_molecule terminated

Quick answer

Selinexor for Colorectal Neoplasm is a Phase 1 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Karyopharm Therapeutics
Indication
Colorectal Neoplasm
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials